Welcome to our dedicated page for OneMedNet SEC filings (Ticker: ONMD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Every OneMedNet filing combines healthcare-privacy regulation, subscription-software accounting, and even Bitcoin treasury notes—all inside documents that often exceed 200 pages. If locating HIPAA risk factors or the latest iRWD™ contract disclosures feels overwhelming, you are not alone.
Stock Titan’s AI reads each submission the moment it hits EDGAR, then delivers clear explanations in plain language. Need the OneMedNet quarterly earnings report 10-Q filing without combing through footnotes? Want OneMedNet insider trading Form 4 transactions or OneMedNet Form 4 insider transactions real-time alerts before the market reacts? Our platform links the exact page, offers sentence-level AI highlights, and answers the natural question, “How are OneMedNet’s SEC filings explained simply?”
Here’s what professionals track on this page:
- OneMedNet annual report 10-K simplified—spot revenue from imaging-data licenses, R&D outlays, and digital asset valuations in minutes.
- OneMedNet proxy statement executive compensation—compare bonuses to shareholder returns without scrolling hundreds of lines.
- OneMedNet 8-K material events explained—from new hospital partnerships to data-security incidents, each event is summarized automatically.
- OneMedNet earnings report filing analysis—AI extracts segment margins and recurring versus non-recurring sales trends.
- “Understanding OneMedNet SEC documents with AI” becomes practical with point-and-click access to OneMedNet executive stock transactions Form 4 and historical charts.
Whether you monitor insider sentiment before a clinical-trial catalyst or audit how digital assets affect cash flow, Stock Titan turns complex health-tech disclosures into actionable knowledge—saving hours and improving confidence in every decision.
OneMedNet Corporation will hold its 2025 Annual Meeting on December 17, 2025 at 11:00 a.m. CT via live audio webcast at https://www.cstproxy.com/onemednet/2025. Stockholders will vote to elect two Class II directors for three-year terms and to ratify WithumSmith+Brown, PC as independent auditor for 2025.
Holders of record on October 23, 2025 may vote; there were 51,157,069 shares of common stock outstanding as of that date. The Board recommends voting FOR both director nominees and FOR auditor ratification. Director Jair Clarke will not stand for re-election; the Board size will be reduced to eight after the meeting.
The Audit Committee reports Withum fees of $840,000 for 2024 (including
Executive updates include RSU awards to leadership and related-party financings and conversions in 2025 involving Dr. Thomas Kosasa and Dr. Jeffrey Yu. As of October 23, 2025, beneficial ownership includes Dr. Kosasa at 30.8% and Dr. Yu at 13.8%.
OneMedNet Corporation announced that director Jair Clarke will not stand for re-election at the Company’s 2025 Annual Meeting of Stockholders. The Company stated his decision was not due to any disagreement with the Company or management. Mr. Clarke will remain on the Board until the Annual Meeting and will continue to serve in an advisory capacity thereafter.
FAQ
What is the current stock price of OneMedNet (ONMD)?
What is the market cap of OneMedNet (ONMD)?
